1. Home
  2. ETON vs GILT Comparison

ETON vs GILT Comparison

Compare ETON & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • GILT
  • Stock Information
  • Founded
  • ETON 2017
  • GILT 1987
  • Country
  • ETON United States
  • GILT Israel
  • Employees
  • ETON N/A
  • GILT N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • GILT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ETON Health Care
  • GILT Technology
  • Exchange
  • ETON Nasdaq
  • GILT Nasdaq
  • Market Cap
  • ETON 428.5M
  • GILT 400.3M
  • IPO Year
  • ETON 2018
  • GILT 1993
  • Fundamental
  • Price
  • ETON $17.07
  • GILT $6.68
  • Analyst Decision
  • ETON Strong Buy
  • GILT Strong Buy
  • Analyst Count
  • ETON 3
  • GILT 2
  • Target Price
  • ETON $27.67
  • GILT $8.50
  • AVG Volume (30 Days)
  • ETON 231.3K
  • GILT 187.4K
  • Earning Date
  • ETON 05-13-2025
  • GILT 05-19-2025
  • Dividend Yield
  • ETON N/A
  • GILT N/A
  • EPS Growth
  • ETON N/A
  • GILT 6.30
  • EPS
  • ETON N/A
  • GILT 0.44
  • Revenue
  • ETON $39,011,000.00
  • GILT $305,448,000.00
  • Revenue This Year
  • ETON $92.33
  • GILT $45.29
  • Revenue Next Year
  • ETON $54.19
  • GILT $11.74
  • P/E Ratio
  • ETON N/A
  • GILT $15.14
  • Revenue Growth
  • ETON 23.29
  • GILT 14.79
  • 52 Week Low
  • ETON $3.18
  • GILT $4.04
  • 52 Week High
  • ETON $18.41
  • GILT $8.05
  • Technical
  • Relative Strength Index (RSI)
  • ETON 62.16
  • GILT 60.07
  • Support Level
  • ETON $16.43
  • GILT $6.44
  • Resistance Level
  • ETON $17.74
  • GILT $6.74
  • Average True Range (ATR)
  • ETON 0.92
  • GILT 0.16
  • MACD
  • ETON 0.06
  • GILT 0.05
  • Stochastic Oscillator
  • ETON 73.09
  • GILT 89.29

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

Share on Social Networks: